Danish Cancer Institute shared a post on LinkedIn:
“Next up in our Summer Social Series: Meet the Scientists is Eva Pais – Ph.D. student in the Genome Integrity Group led by Jiri Bartek.
Eva’s path into science was shaped by her brother’s cancer diagnosis during her childhood – a life-changing moment that sparked her commitment to cancer research. Today, she studies how microtubule inner proteins (MIPs) affect chromosome segregation, aiming to uncover more targeted and less toxic cancer therapies.
Why did you become a scientist?
I was always interested in biology and fascinated by the complexity of the human body. But when my brother was diagnosed with cancer at 16, it truly shaped my path. I was just 12, but that experience solidified my decision to pursue cancer research. Thankfully, he recovered — but the drive to help others facing similar challenges has never left me.
What are you currently working on?
My thesis focuses on characterising microtubule inner proteins (MIPs) and how they affect chromosome segregation. The aim is to uncover new targets for cancer treatment that are both more specific and less toxic for patients.
What I like about my job is…
The dynamic nature of research really excites me. I love how projects evolve and bring unexpected challenges. It’s creative problem-solving on a daily basis — and even though it’s often trial and error, it’s never boring.
What motivates you at work?
For me, it’s about solving complex puzzles and seeing the bigger picture come into focus. Even when things don’t work, I stay motivated by the possibility that the next experiment might bring us one step closer to helping patients.
To me, the DCI is…
A place full of passionate people, all deeply committed to pushing the boundaries of cancer research.
How do you get your mind off research?
Spending time with friends and family, playing computer games, painting – anything creative helps me recharge. It’s important to find balance, even when the project is always calling.”
More posts featuring Danish Cancer Institute on OncoDaily.